480 filings
Page 4 of 24
424B5
MYMD
MyMD Pharmaceuticals Inc
23 Feb 23
Prospectus supplement for primary offering
9:00am
8-K
MYMD
MyMD Pharmaceuticals Inc
21 Feb 23
MyMD Announces $15 Million Offering with Existing Investors
9:00am
SC 13G/A
Iroquois Capital Management, LLC
14 Feb 23
MyMD Pharmaceuticals / Iroquois Capital Management ownership change
7:40am
8-K
MYMD
MyMD Pharmaceuticals Inc
3 Feb 23
Departure of Directors or Certain Officers
4:15pm
8-K
MYMD
MyMD Pharmaceuticals Inc
14 Dec 22
Submission of Matters to a Vote of Security Holders
5:00pm
4
Paul Rivard
8 Dec 22
MyMD Pharmaceuticals / Paul Rivard ownership change
8:24pm
8-K
MYMD
MyMD Pharmaceuticals Inc
8 Dec 22
MyMD Pharmaceuticals® to Present Data on Oral TNF-a Inhibitor MYMD-1® at the British Society for Immunology (BSI) Congress 2022
4:15pm
8-K
MYMD
MyMD Pharmaceuticals Inc
18 Nov 22
MyMD Pharmaceuticals® Announces Upcoming Presentation of Late-Breaking Data for MYMD-1® at the 2022 British Society for Immunology (BSI) Congress
4:30pm
8-K
MYMD
MyMD Pharmaceuticals Inc
14 Nov 22
MyMD Pharmaceuticals Announces Publication of Phase 1 Data for oral TNF-alpha Inhibitor MYMD-1® in Peer-Reviewed Journal Data Research
8:32am
10-Q
2022 Q3
MYMD
MyMD Pharmaceuticals Inc
Quarterly report
10 Nov 22
5:01pm
DEFA14A
MYMD
MyMD Pharmaceuticals Inc
26 Oct 22
Additional proxy soliciting materials
5:19pm
DEF 14A
MYMD
MyMD Pharmaceuticals Inc
Definitive proxy
26 Oct 22
5:15pm
8-K
MYMD
MyMD Pharmaceuticals Inc
20 Sep 22
Efficacy data anticipated in Q4 of 2022
8:00am
SC 13D
Duffey Samuel S
8 Sep 22
MyMD Pharmaceuticals / DUFFEY SAMUEL S ownership change
4:22pm
8-K
MYMD
MyMD Pharmaceuticals Inc
31 Aug 22
Mymd Pharmaceuticals Receives Grant from European
8:00am
D
MYMD
MyMD Pharmaceuticals Inc
30 Aug 22
$7.41M in options / securities to be acquired, 8 investors
8:00am
8-K
MYMD
MyMD Pharmaceuticals Inc
17 Aug 22
Entry into a Material Definitive Agreement
5:16pm
424B5
MYMD
MyMD Pharmaceuticals Inc
17 Aug 22
Prospectus supplement for primary offering
3:00pm
10-Q
2022 Q2
MYMD
MyMD Pharmaceuticals Inc
Quarterly report
15 Aug 22
8:31am
8-K
MYMD
MyMD Pharmaceuticals Inc
3 Aug 22
Regulation FD Disclosure
4:30pm